The cuprizone model is a well-established and investigated paradigm to study demyelination and remyelination in rodents. Cuprizone is usually administrated by mixing in the powdered or pelleted rodent chow. However, since cuprizone is sensitive to the environment and the consumption of it varies between different animals, the major issue is the discrepancy in demyelination of the animals. This study reports the development of the cuprizone model by gavage administrations in mice. Following testing a series of doses of cuprizone, 400 mg/kg/day was found to be the best dosage to induce dramatic and consistent demyelination after 5 weeks of administration; while remyelination quickly occurred after 9 days of cuprizone withdrawal ...
Previous studies have clearly demonstrated the indispensable role of IL-17 in the induction and pathogenesis of EAE, which resembles the pattern I and II MS lesions driven by T cell-mediated autoimmune inflammatory response. In this study, we show for the first time that IL-17-mediated signaling plays a critical role in cuprizone-induced demyelination, which shares similarities with pattern III MS lesions associated with apoptosis of myelin-forming oligodendrocytes and pronounced loss of oligodendrocytes. Interestingly, mice deficient in IL-17A, IL-17RC, and adaptor protein Act1 (of IL-17R) displayed diminished demyelination, microglial accumulation, and leukocyte infiltration compared with that in wild-type mice in response to cuprizone. Importantly, astrocytes are highly responsive to IL-17 in vitro, and selective deletion of Act1 in astrocytes ameliorated cuprizone-induced demyelination. Together, these results suggest that IL-17-mediated signaling in astrocytes contributes to the ...
Figure 1. BM-derived cells are recruited in a CCR2-dependent manner into demyelinating sites of the CNS in the cuprizone model. (A) A Busulfan/Cyclophosphamide chemotherapy regimen was used to prepare WT mice to receive the injection of BM cells from GFP+/− mice. 6 wk after transplantation, 0.2% Cuprizone was added to the diet for up to 6 wk. Mice were sacrificed after 2, 3, 4, 5, and 6 wk on a cuprizone-supplemented diet. Another group was sacrificed 2 wk after removing cuprizone from the diet to allow remyelination. (B) Flow cytometry analysis of GFP expression in circulating monocytes of WT mice, GFP+/− mice, chimeric GFP → WT mice, and and CCR2−/− → WT mice. (C) GFP+ cells were counted with a stereologic apparatus. Reported is the total number of GFP+ cells per slice counted per animal. (D-F) Representative confocal images of GFP+ cells (green) and immunoreactive Iba1+ cells (red) in the hippocampus and corpus callosum of chimeric mice either untreated (D) or after 5 wk of ...
Neurotrophin signaling impacts development and health of oligodendrocyte lineage cells. Brain-derived neurotrophic factor (BDNF) has been of particular interest. BDNF increases DNA synthesis in cultured basal forebrain oligodendrocyte progenitors (Vant Veer et al., 2009) and enhances oligodendrocyte differentiation to myelin protein-expressing cells (Du et al., 2006). Moreover, BDNF deficient mice exhibit deficits in progenitors and myelin protein expression (Vondran et al., 2010) and the conditional knock-out of the BDNF receptor TrkB from mature, MBP+ oligodendrocytes results in reduced myelin thickness in both the spinal cord and the corpus callosum (Wong et al., 2013).. These effects may be relevant to in vivo demyelination. For example, in the cuprizone demyelination model expression of BDNF is decreased in the corpus callosum, and animals deficient in BDNF exhibit a more severe loss of myelin protein in the lesioned corpus callosum than do their wild-type littermates (VonDran et al., ...
Baxi, E.G., DeBruin, J., Jin, J., Strasburger, H.J., Smith, M.D., Orthmann-Murphy, J.L., Schott, J.T., Fairchild, A.N., Bergles, D.E., and Calabresi, P.A. (2017). Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced demyelination. Glia 65, 2087-2098.. Kim, J., Hughes, E.G., Shetty, A.S., Arlotta, P., Goff, L.A., Bergles, D.E., and Brown, S.P. (2017). Changes in the Excitability of Neocortical Neurons in a Mouse Model of Amyotrophic Lateral Sclerosis Are Not Specific to Corticospinal Neurons and Are Modulated by Advancing Disease. J. Neurosci. 37, 9037-9053.. Assinck, P., Duncan, G.J., Plemel, J.R., Lee, M.J., Stratton, J.A., Manesh, S.B., Liu, J., Ramer, L.M., Kang, S.H., Bergles, D.E., et al. (2017). Myelinogenic Plasticity of Oligodendrocyte Precursor Cells following Spinal Cord Contusion Injury. J. Neurosci. 37, 8635-8654.. Langseth, A.J., Kim, J., Ugolino, J.E., Shah, Y., Hwang, H.-Y., Wang, J., Bergles, D.E., and Brown, S.P. (2017). ...
The present study aimed to orally deliver methylthioadenosine (MTA) to the brain employing solid lipid nanoparticles (SLNs) for the management of neurological conditions like multiple sclerosis. The stearic acid-based SLNs were below 100 nm with almost neutral zeta potential and offered higher drug entrapment and drug loading. Cuprizone-induced demyelination model in mice was employed to mimic the multiple sclerosis-like conditions. It was observed that the MTA-loaded SLNs were able to maintain the normal metabolism, locomotor activity, motor coordination, balancing, and grip strength of the rodents in substantially superior ways vis-à-vis plain MTA. Histopathological studies of the corpus callosum and its subsequent staining with myelin staining dye luxol fast blue proved the potential of MTA-loaded SLNs in the remyelination of neurons. The pharmacokinetic studies provided the evidences for improved bioavailability and enhanced bioresidence supporting the pharmacodynamic findings. The studies ...
Charles River conducts studies in both inflammation-induced and demyelination in vivo MS models (cuprizone model and EAE model) to test the efficacy of novel therapeutics.
A study shows that the natural metabolite taurine appears to boost remyelination and the effectiveness of current multiple sclerosis (MS) therapies.
Walsh DA, Merson TD, Landman KA, Hughes BD. (2016) Evidence for Cooperative Selection of Axons for Myelination by Adjacent Oligodendrocytes in the Optic Nerve. PLoS ONE 11 (11): e0165673. Walsh DA, Röth PT, Holmes WR, Landman KA, Merson TD, Hughes BD. (2016) Is cell migration or proliferation dominant in the formation of linear arrays of oligodendrocytes? J Theor Biol 406:17-30.. Huang L, Merson TD, Bourne JA. (2016) In vivo whole brain, cellular and molecular imaging in nonhuman primate models of neuropathology. Neurosci Biobehav Rev 66:104-118.. Mitew S, Xing YL, Merson TD. (2016) Axonal activity-dependent myelination in development: insights for myelin repair. J Chem Neuroanat pii: S0891-0618(16)30029-1. Xing YL, Röth PT, Stratton JA, Chuang BHA, Danne J, Ellis SL, Ng SW, Kilpatrick TJ, Merson TD. (2014) Adult neural precursor cells from the subventricular zone contribute significantly to oligodendrocyte regeneration and remyelination. J Neurosci 34:14128-46.. Merson TD, Bourne JA. (2014) ...
Walsh DA, Merson TD, Landman KA, Hughes BD. (2016) Evidence for Cooperative Selection of Axons for Myelination by Adjacent Oligodendrocytes in the Optic Nerve. PLoS ONE 11 (11): e0165673. Walsh DA, Röth PT, Holmes WR, Landman KA, Merson TD, Hughes BD. (2016) Is cell migration or proliferation dominant in the formation of linear arrays of oligodendrocytes? J Theor Biol 406:17-30.. Huang L, Merson TD, Bourne JA. (2016) In vivo whole brain, cellular and molecular imaging in nonhuman primate models of neuropathology. Neurosci Biobehav Rev 66:104-118.. Mitew S, Xing YL, Merson TD. (2016) Axonal activity-dependent myelination in development: insights for myelin repair. J Chem Neuroanat pii: S0891-0618(16)30029-1. Xing YL, Röth PT, Stratton JA, Chuang BHA, Danne J, Ellis SL, Ng SW, Kilpatrick TJ, Merson TD. (2014) Adult neural precursor cells from the subventricular zone contribute significantly to oligodendrocyte regeneration and remyelination. J Neurosci 34:14128-46.. Merson TD, Bourne JA. (2014) ...
Radiotherapy is the mainstay of treatment after surgery for high-grade gliomas and is usually well tolerated. Radiation toxicity in the brain is usually classified according to the timing of side effects in relation to treatment, as either acute (during radiotherapy), early delayed (within 12 weeks of radiotherapy) or late delayed (months to years after radiotherapy). We report two cases of young women who developed severe acute demyelination within 4 months of radiotherapy for glioma, one of whom had a previous history of transverse myelitis. Both improved with corticosteroids and remain in tumour remission. These cases emphasise the importance of careful discussion with patients before starting radiotherapy if there is a previous history of central nervous system demyelination or multiple white matter lesions on MRI. ...
High resolution diffusion tensor images of the mouse brain were acquired using the pulsed gradient spin echo sequence and the oscillating gradient spin echo sequence. The oscillating gradient spin echo tensor images demonstrated frequency-dependent changes in diffusion measurements, including apparent diffusion coefficient and fractional anisotropy, in major brain structures. Maps of the rate of change in apparent diffusion coefficient with oscillating gradient frequency revealed novel tissue contrast in the mouse hippocampus, cerebellum, and cerebral cortex. The observed frequency-dependent contrasts resembled neuronal soma-specific Nissl staining and nuclei-specific 4,6-diamidino-2-phenylindole (DAPI) staining in the mouse brain, which suggests that the contrasts might be related to key features of cytoarchitecture in the brain. In the mouse cuprizone model, oscillating gradient spin echo-based diffusion MRI revealed significantly higher frequency-dependence of perpendicular diffusivity (λ() ...
Demyelinating diseases, such as multiple sclerosis and leukodystrophy, are characterized by damage to the protective myelin sheath that surrounds the axons of neurons. This demyelination can be caused by an autoimmune response or impaired myelin production by oligodendrocytes.. A new report in JCI Insight from Arjun Saha and colleagues at Duke University demonstrates that a cell therapy product called DUOC-01 can accelerate remyelination of axons in mice treated with a demyelinating chemical agent. DUOC-01 cells, which are derived from banked umbilical cord blood, were transplanted into mice following toxic demyelination. DUOC-01 treatment resulted in faster remyelination and promoted the differentiation of oligodendrocyte progenitor cells. These results suggest that a cord blood-derived cell product can promote neuronal repair and remyelination. Future clinical studies will be needed to determine if DUOC-01 cell therapy benefits patients with demyelinating diseases.. ...
Both diets decreased disease severity compared to the control group but the Ketogenic Diet had more modest effects and did not reverse EAE progression in mice. The FMD mice group had clinical reductions to disease symptoms including higher blood levels of corticosterone, improvements in cytokines and T- Cells and a.. May 26, 2016. Moreover, the FMD promoted oligodendrocyte precursor cell regeneration and remyelination in axons in both EAE and cuprizone MS models, supporting its effects on both suppression of autoimmunity and remyelination. We also report preliminary data suggesting that an FMD or a chronic ketogenic diet.. A ketogenic diet. this is the diet for you. Instead, the idea is to rotate when and what you eat in three different phases to put your metabolism into overdrive. The FMD focuses on eating real food and cutting out fad diet nonsense like.. 5 day water fast results tracked via blood ketones, blood glucose and weight. Step by step walk through and experiences of several ...
Individual Test Kits (Copper) A yellow color is formed when copper reacts with diethyldithiocarbamate (DDC). A blue color is formed when copper reacts with cuprizone. ...
B,C) Analysis indicates the total distance was unchanged between cuprizone-exposed mice with or without clemastine treatment (B), but the distance in the central field decreased upon 6-week exposure to cuprizone, while clemastine gradually rescued the behavioral change (C). *P ...
There is much evidence to support the goal of remyelination as a means to prevent axon degeneration and slow deficit progression in neurologic disease [14]. In the year 2000, we reported the identification of a natural human IgM that promoted robust spinal cord remyelination in both the TMEV-IDD and lysolecithin-induced demyelination models [15, 16]. A recombinant form of this human IgM, termed rHIgM22, was expressed in a F3B6 cell line with the assembled IgM containing a mouse J chain [17]. rHIgM22 binds to myelin and the surface of oligodendrocytes (OL) and in pre-clinical studies is effective in vivo at very low doses. A single 0.025 mg/kg intraperitoneal injection of rHIgM22 given to TMEV-IDD mice with demyelination promoted significant remyelination 5 weeks later [18] and increased brainstem NAA concentrations [13], indicating a preservation of axon health [19]. In a recently concluded dose escalation clinical trial in humans with MS, rHIgM22 was tested at doses ranging from 0.025 up to 2 ...
If this is your first visit, be sure to check out the FAQ by clicking the link above. You may have to register before you can post: click the register link above to proceed. To start viewing messages, select the forum that you want to visit from the selection below ...
Valery, Patricia C., Lucas, Robyn M., Williams, David B., Pender, Michael P., Chapman, Caron, Coulthard, Alan, Dear, Keith, Dwyer, Terence, Kilpatrick, Trevor. J., McMichael, Anthony J., van, der Mei, Ingrid, Taylor, Bruce and Ponsonby, Anne-Louise (2013). Occupational Exposure and Risk of Central Nervous System Demyelination. American Journal of Epidemiology,177(9):954-961. ...
Neuroprotective approaches for central nervous system regeneration have not been successful in clinical practice so far and compounds that enhance remyelination are still not available for patients with multiple sclerosis. The objective of this study was to determine potential regenerative effects of the substance cytidine-5-diphospho (CDP)-choline in two different mouse animal models of multiple sclerosis. The effects of exogenously applied CDP-choline were tested in mouse myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. In addition, the cuprizone-induced mouse model of de- and remyelination was used to specifically test the hypothesis that CDP-choline directly increases remyelination. We found that CDP-choline ameliorated the disease course of experimental autoimmune encephalomyelitis and exerted beneficial effects on myelin, oligodendrocytes and axons. After cuprizone-induced demyelination, CDP-choline effectively enhanced myelin regeneration and ...
The pathogenesis of murine hepatitis virus, strain JHM, was studied in 6- and 12-week-old C57iBL mice. There was 100% mortality in the 6-week-old mice after intracerebral inoculation. The lesions were characterized by necrotizing encephalomyelitis, without demyelination. Intracerebral inoculation of 12-week-old animals, however, resulted in no morbidity or mortality. The 12-week-old animals showed transient virus replication in the brain, spinal cord, and liver, which was cleared by day 14. Histologic examination showed evidence of ongoing demyelination, concomitant remyelination, and hydrocephalus ex vacuo. Although viral antigen was demonstrated by immunofluorescence in the central nervous system of these animals, no infectious virus was recovered, and immunosuppression regimens did not potentiate the disease.. ...
This study provides compelling evidence that in marmoset EAE, which forms lesions strongly resembling those of MS, early changes in vascular permeability are associated with perivascular inflammatory cuffing and parenchymal microglial activation but precede the arrival of blood-derived monocytes tha …
Read about Endece receiving a n additional U.S. patent covering NDC-1308 therapy, seen in early studies to have potential to induce remyelination in MS.
Although our knowledge about the formation of oligodendrocytes and their progenitors has grown enormously during the past two decades, the formulation of specif...
Multiple Sclerosis (MS) is an inflammatory disease which causes areas of demyelination in the Central Nervous System (CNS) and affects only humans. Current therapies for MS are focused on anti-inflammatory treatment, which reduce the occurrence and clinical relapses of the disease. However, progressive disability of the disease is related to axonal degeneration. After demyelination, remyelination occurs, which helps repair the demyelinated lesions and protects axons from degeneration. However, this endogenous remyelination is inefficient, and currently there are no therapies available to enhance remyelination. The aim of this thesis was to first characterize a fast and reliable model to study CNS remyelination in vitro, and second to investigate the role of semaphorin 3a (Sema3A) and semaphorin 3f (Sema3F) signaling in CNS remyelination. Various in vivo models have been developed to investigate the pathology of multiple sclerosis, and can be used to test remyelination therapies. However, in vivo ...
However, French Secretary of State for Health Dr Bernard Kouchner took the decision to ban the jab in light of evidence that the vaccine could cause multiple sclerosis or other forms of central nervous system demyelination. Studies in both France and Britain have shown that, in school aged children, the risk of demyelinating reactions in the central nervous system increases during the two months after vaccination (BMJ, 1998; 317: 1034 ...
SUPERVISORS: OLE DIDRIK LÆRUM, ØYSTEIN BRUSERUD 2000 DR.MED. PEER KÅRE LILLENG. TUMOUR CELLS IN THE AXILLARY NODES IN PATIENTS WITH BREAST CANCER. SUPERVISORS: FLORA HARTVEIT, BJØRN MÆHLE.. 1999 DR.MED. HANS KRISTIAN HAUGLAND. MODULATION OF INVASIVE BEHAVIOR IN CULTURED HUMAN GLIOMA CELLS. SUPERVISOR: OLE DIDRIK LÆRUM. 1998 DR.MED. LARS BØ. MULTIPLE SCLEROSIS. IMMUNOPATHOLOGICAL STUDIES OF INFLAMMATORY CENTRAL NERVOUS SYSTEM DEMYELINATION. SUPERVISOR: SVERRE MØRK. 1999 DR.MED. LARS FJELLBIRKELAND. THREE-DIMENSIONAL CULTURE OF HUMAN BRONCHIAL MUCOSA AND LUNG CANCER TISSUE. SUPERVISORS: OLE DIDRIK LÆRUM, ROLF BJERKVIG. 1998 DR.MED. JOHANNA OLWEUS. EARLY EVENTS IN HUMAN MYELOPOIESIS. SUPERVISORS: OLE DIDRIK LÆRUM, FRIDTJOF LUND-JOHANSEN. 1998 DR.MED. SVEIN JACOB TJOFLAAT NYGAARD. DYNAMIC DETERMINATION AND MODULATION OF GLIOMA CELL INVASION IN VITRO. SUPERVISORS: OLE DIDRIK LÆRUM, OLE BJØRN TYSNES. 1998 DR.MED. KARIN COLLETT. OPERABLE BREAST CANCER. SUPERVISORS: BJØRN MÆHLE, ROLV ...
Central nervous system (CNS) myelination is important for proper nervous system function in vertebrates. In demyelinating diseases such as multiple sclerosis, autoimmune-mediated myelin destruction results in neurological impairment; and although remyelination does occur spontaneously, it is poorly understood and insufficient in humans. Zebrafish (Danio rerio) are known to harbour tremendous regenerative capacity of various CNS tissues; however, there is presently only little knowledge of their myelin repair efficiency. An experimental model of myelin injury in zebrafish would permit study of the mechanisms involved in successful remyelination and could potentially guide the development of novel therapeutic agents for mammalian remyelination. This doctoral thesis describes the characterisation of the novel myelin protein Claudin k in zebrafish, demonstrates the establishment of adult zebrafish as an experimental model for CNS de- and remyelination and explores some mechanisms underlying myelin ...
Magnetization transfer imaging represents an attempt to develop contrast in MR imaging on the basis of submolecular exchange processes that may occur in biological tissue (21). This technique has some clinical and research applications in the study of different CNS disorders (22), because it affords a potential window into the macromolecular environment that is not directly visible using conventional techniques (21). Therefore, it enables the assessment of "invisible" disease in the so-called normal-appearing white matter (23-25), and, with the application of MTR, it provides a means to quantify disease burden (26).. Experimental and human studies support the hypothesis that demyelination and axonal loss are the main contributors to the MTR decrease observed in association with several pathologic conditions, such as experimental autoimmune encephalomyelitis (12), toxic demyelination (27), progressive multifocal leukoencephalopathy (28), human immunodeficiency virus encephalitis (28), and ...
Dr Jessica Fletcher, funded by an MS Research Australia Postdoctoral Fellowship, with the support of the Trish MS Research Foundation, has been working with Dr Simon Murray and Dr Junhua Xiao at The University of Melbourne, investigating novel molecular targets for promoting remyelination in the brain. Myelin coats the nerve cells in the brain and spinal cord. In MS there is damage to the myelin, and in the early stages of the disease there is some ability to repair the myelin, a process known as remyelination. Over time the bodys ability to remyelinate becomes impaired, leading to incomplete repair and contributing to the progression of MS symptoms. It is crucial to identify potential new treatment targets that can promote myelin repair, prevent nerve damage and halt MS disease progression.. Dr Fletcher has been working on a nerve growth factor, known as brain-derived neurotrophic factor (BDNF), which has been found to promote myelination by activating different receptors, or docking stations, ...
Read about an MS study showing the protein EphrinB3 blocks remyelination by inhibiting oligodendrocyte formation, and suggesting it as a treatment target.
... can be extensive in multiple sclerosis despite a long disease course 21 April 2007 Patani R, Balaratnam M, Vora A, Reynolds R. Department of Cellular and Molecular Neuroscience, UK MS Tissue Bank, Division of Neuroscience, Imperial College London, Charing ...
Research on myelination offers centered on identifying molecules capable of inducing oligodendrocyte (OL) differentiation in an effort to develop strategies that promote functional myelin regeneration in demyelinating disorders. of and gene manifestation, mediated from the connection of SMAD3/4 with Sp1 and FoxO1 transcription factors. Our study is the 1st to demonstrate an autonomous and important part of TGF signaling in OL development and CNS myelination, and may provide new avenues in the treatment of demyelinating diseases. studies have shown that O-2A progenitor cells express TGF1 and that TGF signaling activation exerts an anti-mitogenic effect countering PDGFR signaling, in turn promoting cell cycle arrest (McKinnon et al., 1993). Moreover, Activin-A, a member of the TGF superfamily, has been proposed as one of the cytokines secreted by microglial cells that plays a role in OL regeneration and remyelination (Miron et al., 2013). These scholarly research claim that TGF signaling could be ...
TY - PAT. T1 - Treatment of Demyelinating Disorders with Soluble Lymphotoxin-Beta-Receptor. AU - Browning,Jeffrey L.. AU - Ting,Jenny P-Y. N1 - Status: published applicationnumber: 12/446,041 usclass: 514/19.2 ; 514/1.1; 530/351 applicationnumber: 12/446,041. PY - 1800. Y1 - 1800. N2 - Methods of treating a demyelinating disorder using inhibitors of the lymphotoxin pathway.. AB - Methods of treating a demyelinating disorder using inhibitors of the lymphotoxin pathway.. M3 - Patent. M1 - 8067375. ER - ...
Remyelination is the process of propagating oligodendrocyte precursor cells to form oligodendrocytes to create new myelin sheaths on demyelinated axons in the CNS. This is a process naturally regulated in the body and tends to be very efficient in a healthy CNS. The process creates a thinner myelin sheath than normal, but it helps to protect the axon from further damage, from overall degeneration, and proves to increase conductance once again. Demyelinating diseases, such as Multiple Sclerosis, have been of utmost interest within the last couple of decades. Recent research is uncovering some of the many unknown pathways involved with remyelination in hopes of battling demyelinating diseases like MS which can ultimately cripple a person. While no treatment exists yet in preventing remyelination failure in the chronic stages of these diseases, future research may yet prove to unlock key pathways that can be targeted. Remyelination is activated and regulated by a variety of factors surrounding ...
We set up the Cambridge Centre for Myelin Repair in 2005, with the aim of developing treatments that promote myelin repair for people with MS.. Since it opened the Cambridge Centre has created a world-class research environment involving researchers from all around the UK - most notably at our Edinburgh Centre for MS Research.. Scientists at both centres have worked together to show that a molecule called RXR-gamma could encourage the brains own stem cells to repair myelin in animal models of MS. Researchers will now test the benefits of a drug that targets RXR-gamma, called bexarotene, in a phase 2 clinical trial.. We announced four more years of funding for the Cambridge Centre in 2016. Researchers will continue to investigate the fundamental mechanisms behind myelin repair, with the hope of developing new treatments.. They will focus on understanding more about the cells capable of repairing myelin, and the impact ageing and lifestyle factors (such as diet and exercise) can have on these ...
In the present study, we show that hypomyelination in the MLIV mouse brain is associated with decreased expression of both precursor and mature oligodendrocyte markers, as well as a decrease in the number of postmitotic oligodendrocytes. Our observation of delayed myelin deposition during early postnatal brain development highlights the developmental character of brain pathology in MLIV. Interestingly, our data also indicate that the fate of developing oligodendrocytes is affected differently in the white (corpus callosum) versus gray (neocortex) matter of the brain as indicated by changes in CC+ cell counts (Fig. 4) or PLP and MBP staining intensities in these brain regions. This suggests that the tissue microenvironment and factors released by neighboring cells can contribute to the ability of Mcoln1−/− oligodendrocytes to develop, survive and/or produce myelin. Despite these region-specific changes within the brain, our data demonstrate that TRPML1 is an important regulator of ...
Demyelinating Disorders of the Central Nervous System in Childhood von Chabas/Waubant Chabas/Waubant und Buchbewertungen gibt es auf ReadRate.com. Bücher können hier direkt online erworben werden.
Dr. Fabrizio Salvi- Head neurologist at the University of Bologna spoke of his clinical observations as a neurologist working with the CCSVI paradigm for three years. He told us that in 500 MS patients he has tested now, 100% have CCSVI. He stated the doppler is a wonderful tool of diagnosis and their needs to be training in the technique. He has a hypothesis as to why there are different varieties of screening in high risk subjects- because prognosis is related to the type of malformation. He wants to answer the question if the Liberation procedure is a disease modifying treatment in MS. He will give proof tomorrow that there is plasticity and remyelination in the CNS and the Liberation procedure have proven to activate remyelination in the CNS as shown by MRI ...
Video articles in JoVE about myelin basic proteins include Monitoring Cleaved Caspase-3 Activity and Apoptosis of Immortalized Oligodendroglial Cells using Live-cell Imaging and Cleaveable Fluorogenic-dye Substrates Following Potassium-induced Membrane Depolarization.
Graham S.T. Smith is the author of this article in the Journal of Visualized Experiments: Monitoring Cleaved Caspase-3 Activity and Apoptosis of Immortalized Oligodendroglial Cells using Live-cell Imaging and Cleaveable Fluorogenic-dye Substrates Following Potassium-induced Membrane Depolarization
Current treatment modalities for the neurodegenerative disease multiple sclerosis (MS) use disease-modifying immunosuppressive compounds but do not promote repair. Although several potential targets that may induce myelin production have been identified, there has yet to be an approved therapy that promotes remyelination in the damaged central nervous system (CNS). Remyelination of damaged axons requires the generation of new oligodendrocytes from oligodendrocyte progenitor cells (OPCs). Although OPCs are detected in MS lesions, repair of myelin is limited, contributing to progressive clinical deterioration. In the CNS, the chemokine CXCL12 promotes remyelination via CXCR4 activation on OPCs, resulting in their differentiation into myelinating oligodendrocytes. Although the CXCL12 scavenging receptor CXCR7/ACKR3 (CXCR7) is also expressed by OPCs, its role in myelin repair in the adult CNS is unknown. ...
... is a chapter in the book, Neurology, containing the following 2 pages: Multiple Sclerosis, Guillain Barre Syndrome.
MS Focus: the Multiple Sclerosis Foundation provides grants and services to meet the critical needs of people with MS and their families.
Lastly, whenever you have unread items in the topics youve subscribed to, the "Alerts" icon will light up in the main menu. Just click on the bell to see your five most-recent, unread notifications ...
Myelin is the insulation sheath around nerve fibres. If this protective layer is injured, the affected nerves are no longer functional. The adult brain contains …
Demyelination of CNS axons occurs in a number of pathological conditions, including multiple sclerosis and contusion-type spinal cord injury. The demyelination can be repaired by remyelination in both humans and rodents, and even within the CNS remyelination can be achieved by endogenous and/or exogenous Schwann cells, the myelinating cells of the PNS. Remyelinated axons can often conduct impulses securely, but the organization of ion channels at long-term remyelinated nodes is not known. In the present study, the expression of voltage-gated sodium (Nav) and potassium (Kv) channels along central axons remyelinated by endogenous Schwann cells has been studied in lesions induced more than 1 year previously by the intraspinal injection of ethidium bromide (EB). The expression of the channels at long-term nodes formed by Schwann cell remyelination has been compared with that present in nascent nodes formed in the adult at 18 and 23 days post-EB injection. Immunohistochemical studies revealed that ...
Loss of oligodendrocytes in multiple sclerosis (MS) leads to demyelination and axonal dysfunction and transection. Myelin repair, or remyelination, not only restores proper axonal conduction, but also protects axons from degeneration. Oligodendrocytes are myelin-producing cells and are generated from oligodendrocyte progenitor cells (OPCs). Although spontaneous production of oligodendrocytes and consequent remyelination do occur in early phases of MS, the efficiency decreases over time as the disease progresses. Therapeutic interventions to stimulate oligodendrocyte production and remyelination efficiency are likely to reduce disease progression and neurological disability ...
Early in 2016 Dr David Gonsalvez was awarded a prestigious Betty Cuthbert Postdoctoral Fellowship co-funded by National Health and Medical Research Council / MS Research Australia, with MS Research Australias contribution provided with full funding support from the Trish MS Research Foundation. MS results from the damage and loss of myelin, the conductive layer present around nerve fibres in the brain and spinal cord. This makes the nerve fibres unable to transmit their electrical signals, but also leaves the nerves very vulnerable to permanent damage. Myelin can be repaired, but this process is often incomplete and the failure of remyelination is thought to contribute to the development of the secondary progressive form of MS. At the moment there are no treatment options available that promote the repair of myelin to restore lost function and prevent further disability in people with MS. It is known the myelin repair is inhibited by some of the chemicals and physical features associated with ...
An innovative funding scheme generates ground-breaking progress in understanding the genetic changes in MS as well as myelin repair.